GlobeNewswire Inc.··Telix Pharmaceuticals LimitedFDA Accepts Telix's Pixclara NDA for Glioma Imaging; Decision Due Sept. 2026
FDA accepts Telix's Pixclara NDA for glioma imaging with September 2026 decision target. Orphan Drug designation provides competitive advantages.
TLXFDA approvalradiopharmaceuticals